Literature DB >> 26912748

Predictability of Phenotype in Relation to Common β-Lactam Resistance Mechanisms in Escherichia coli and Klebsiella pneumoniae.

Alex Agyekum1, Alicia Fajardo-Lubián2, Xiaoman Ai1, Andrew N Ginn1, Zhiyong Zong1, Xuejun Guo1, John Turnidge3, Sally R Partridge1, Jonathan R Iredell2.   

Abstract

The minimal concentration of antibiotic required to inhibit the growth of different isolates of a given species with no acquired resistance mechanisms has a normal distribution. We have previously shown that the presence or absence of transmissible antibiotic resistance genes has excellent predictive power for phenotype. In this study, we analyzed the distribution of six β-lactam antibiotic susceptibility phenotypes associated with commonly acquired resistance genes in Enterobacteriaceae in Sydney, Australia. Escherichia coli (n = 200) and Klebsiella pneumoniae (n = 178) clinical isolates, with relevant transmissible resistance genes (blaTEM, n = 33; plasmid AmpC, n = 69; extended-spectrum β-lactamase [ESBL], n = 116; and carbapenemase, n = 100), were characterized. A group of 60 isolates with no phenotypic resistance to any antibiotics tested and carrying none of the important β-lactamase genes served as comparators. The MICs for all drug-bacterium combinations had a normal distribution, varying only in the presence of additional genes relevant to the phenotype or, for ertapenem resistance in K. pneumoniae, with a loss or change in the outer membrane porin protein OmpK36. We demonstrated mutations in ompK36 or absence of OmpK36 in all isolates in which reduced susceptibility to ertapenem (MIC, >1 mg/liter) was evident. Ertapenem nonsusceptibility in K. pneumoniae was most common in the context of an OmpK36 variant with an ESBL or AmpC gene. Surveillance strategies to define appropriate antimicrobial therapies should include genotype-phenotype relationships for all major transmissible resistance genes and the characterization of mutations in relevant porins in organisms, like K. pneumoniae.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26912748      PMCID: PMC4844708          DOI: 10.1128/JCM.02153-15

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  65 in total

1.  Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum beta-lactamase CTX-M-15 and of its structurally related beta-lactamase CTX-M-3.

Authors:  Laurent Poirel; Marek Gniadkowski; Patrice Nordmann
Journal:  J Antimicrob Chemother       Date:  2002-12       Impact factor: 5.790

Review 2.  The CTX-M beta-lactamase pandemic.

Authors:  Rafael Cantón; Teresa M Coque
Journal:  Curr Opin Microbiol       Date:  2006-08-30       Impact factor: 7.934

3.  Effect of porins and plasmid-mediated AmpC beta-lactamases on the efficacy of beta-lactams in rat pneumonia caused by Klebsiella pneumoniae.

Authors:  Emma Padilla; Diana Alonso; Antonio Doménech-Sánchez; Cristina Gomez; José Luis Pérez; Sebastián Albertí; Nuria Borrell
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

4.  Plasmid replicon typing of commensal and pathogenic Escherichia coli isolates.

Authors:  Timothy J Johnson; Yvonne M Wannemuehler; Sara J Johnson; Catherine M Logue; David G White; Curt Doetkott; Lisa K Nolan
Journal:  Appl Environ Microbiol       Date:  2007-02-02       Impact factor: 4.792

Review 5.  The complexities of porin genetic regulation.

Authors:  Miguel Angel De la Cruz; Edmundo Calva
Journal:  J Mol Microbiol Biotechnol       Date:  2010-01-06

Review 6.  Plasmids and the spread of resistance.

Authors:  Alessandra Carattoli
Journal:  Int J Med Microbiol       Date:  2013-03-14       Impact factor: 3.473

7.  Identification of plasmids by PCR-based replicon typing.

Authors:  Alessandra Carattoli; Alessia Bertini; Laura Villa; Vincenzo Falbo; Katie L Hopkins; E John Threlfall
Journal:  J Microbiol Methods       Date:  2005-06-02       Impact factor: 2.363

8.  Characterization of the extended-spectrum beta-lactamase reference strain, Klebsiella pneumoniae K6 (ATCC 700603), which produces the novel enzyme SHV-18.

Authors:  J K Rasheed; G J Anderson; H Yigit; A M Queenan; A Doménech-Sánchez; J M Swenson; J W Biddle; M J Ferraro; G A Jacoby; F C Tenover
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

Review 9.  OXA-48-like carbapenemases: the phantom menace.

Authors:  Laurent Poirel; Anaïs Potron; Patrice Nordmann
Journal:  J Antimicrob Chemother       Date:  2012-04-11       Impact factor: 5.790

Review 10.  AmpC beta-lactamases.

Authors:  George A Jacoby
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

View more
  13 in total

1.  Whole-Genome Sequencing and Concordance Between Antimicrobial Susceptibility Genotypes and Phenotypes of Bacterial Isolates Associated with Bovine Respiratory Disease.

Authors:  Joseph R Owen; Noelle Noyes; Amy E Young; Daniel J Prince; Patricia C Blanchard; Terry W Lehenbauer; Sharif S Aly; Jessica H Davis; Sean M O'Rourke; Zaid Abdo; Keith Belk; Michael R Miller; Paul Morley; Alison L Van Eenennaam
Journal:  G3 (Bethesda)       Date:  2017-09-07       Impact factor: 3.154

2.  Vaborbactam: Spectrum of Beta-Lactamase Inhibition and Impact of Resistance Mechanisms on Activity in Enterobacteriaceae.

Authors:  Olga Lomovskaya; Dongxu Sun; Debora Rubio-Aparicio; Kirk Nelson; Ruslan Tsivkovski; David C Griffith; Michael N Dudley
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

3.  Case Report of an Extensively Drug-Resistant Klebsiella pneumoniae Infection With Genomic Characterization of the Strain and Review of Similar Cases in the United States.

Authors:  Fiorella Krapp; Egon A Ozer; Chao Qi; Alan R Hauser
Journal:  Open Forum Infect Dis       Date:  2018-04-06       Impact factor: 3.835

4.  Specialised functions of two common plasmid mediated toxin-antitoxin systems, ccdAB and pemIK, in Enterobacteriaceae.

Authors:  Alma Y Wu; Muhammad Kamruzzaman; Jonathan R Iredell
Journal:  PLoS One       Date:  2020-06-30       Impact factor: 3.240

5.  Molecular Characterization of Carbapenem Resistant Klebsiella pneumoniae and Klebsiella quasipneumoniae Isolated from Lebanon.

Authors:  Harout Arabaghian; Tamara Salloum; Sahar Alousi; Balig Panossian; George F Araj; Sima Tokajian
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

6.  OmpK36-mediated Carbapenem resistance attenuates ST258 Klebsiella pneumoniae in vivo.

Authors:  Joshua L C Wong; Maria Romano; Louise E Kerry; Hok-Sau Kwong; Wen-Wen Low; Stephen J Brett; Abigail Clements; Konstantinos Beis; Gad Frankel
Journal:  Nat Commun       Date:  2019-09-02       Impact factor: 14.919

7.  The Inc FII Plasmid and its Contribution in the Transmission of blaNDM-1 and blaKPC-2 in Klebsiella pneumoniae in Egypt.

Authors:  Eman Ramadan Mohamed; Mamdouh Yones Ali; Nancy G F M Waly; Hamada Mohamed Halby; Rehab Mahmoud Abd El-Baky
Journal:  Antibiotics (Basel)       Date:  2019-12-13

8.  A genomic surveillance framework and genotyping tool for Klebsiella pneumoniae and its related species complex.

Authors:  Margaret M C Lam; Ryan R Wick; Stephen C Watts; Louise T Cerdeira; Kelly L Wyres; Kathryn E Holt
Journal:  Nat Commun       Date:  2021-07-07       Impact factor: 14.919

9.  Diversity of P1 phage-like elements in multidrug resistant Escherichia coli.

Authors:  Carola Venturini; Tiziana Zingali; Ethan R Wyrsch; Bethany Bowring; Jonathan Iredell; Sally R Partridge; Steven P Djordjevic
Journal:  Sci Rep       Date:  2019-12-11       Impact factor: 4.379

10.  Systematic Review of Plasmid AmpC Type Resistances in Escherichia coli and Klebsiella pneumoniae and Preliminary Proposal of a Simplified Screening Method for ampC.

Authors:  Enrique Rodríguez-Guerrero; Juan Carlos Callejas-Rodelas; José María Navarro-Marí; José Gutiérrez-Fernández
Journal:  Microorganisms       Date:  2022-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.